drugset / Trial / NCT03855228

Safety and Efficacy of Mometasone Furoate Nasal Spray With the Addition of Loratadine Versus Placebo in Participants With Seasonal Allergic Rhinitis (C94-145)

NCT03855228

Phase 3 Completed 704 enrolled Organon and Co
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the safety and efficacy of mometasone furoate nasal spray (MFNS) with the addition of loratadine vs MFNS alone, loratadine alone, or placebo, in the treatment of patients with seasonal allergic rhinitis.

Timeline

Start
1995-03-01
Primary completion
1995-08-07
Completion
1995-08-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Loratadine Small molecule 10 mg Oral
Subject Mometasone furoate Other / unclassified 200 ug Intranasal

Indications